Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: A randomized controlled trial

American Journal of Kidney Diseases

Volumn 64, Issue 6, 2014, Pages 892-901

  Kjaergaard, Krista Dybtved ^a,b   Peters, Christian Daugaard ^a,b   Jespersen, Bente ^a,b   Tietze, Ida Nørager ^c   Madsen, Jens Kristian ^a   Pedersen, Birgitte Bang ^d   Novosel, Marija Kristina ^e   Laursen, Kathrine Skaaning ^d   Bibby, Bo Martin ^b   Strandhave, Charlotte ^d   Jensen, Jens Dam ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c VIBORG HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e Fredericia Sygehus   (Denmark)

Author keywords

Adult; albuminuria; aldosterone; angiotensin II; angiotensin II receptor blocker; anuria double blinded glomerular filtration rate (GFR); GFR decline; hemodialysis (HD); investigator initiated; irbesartan multicenter study; placebo; preservation of residual renal function; randomized controlled trial; rennin; residual renal function; SAFIR (Saving Residual Renal Function in Hemodialysis Patients Receiving Irbesartan) trial; urine volume

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CREATININE; IRBESARTAN; LOOP DIURETIC AGENT; PLACEBO; UREA; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN DERIVATIVE; BIPHENYL DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; ALBUMINURIA; ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ANURIA; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS PATIENT; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; INFECTION; KIDNEY CLEARANCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX RATIO; SYSTOLIC BLOOD PRESSURE; URINE VOLUME; AGED; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECTS; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSINS; BIPHENYL COMPOUNDS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TETRAZOLES;

EID: 84911370935     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.05.011     Document Type: Article

References (18)

1. A.J. Collins, R.N. Foley, and C. Herzog Excerpts from the US Renal Data System 2009 Annual Data Report Am J Kidney Dis 55 1)(suppl 1 2010 S1 S420 A6-A7
2. D. Shemin, A.G. Bostom, P. Laliberty, and L.D. Dworkin Residual renal function and mortality risk in hemodialysis patients Am J Kidney Dis 38 1 2001 85 90
3. W.M. van der Wal, M. Noordzij, and F.W. Dekker Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model Nephrol Dial Transplant 26 9 2011 2978 2983
4. F. Termorshuizen, F.W. Dekker, J.G. van Manen, J.C. Korevaar, E.W. Boeschoten, and R.T. Krediet Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2 J Am Soc Nephrol 15 4 2004 1061 1070
5. M. Fernandez-Lucas, J.L. Teruel-Briones, A. Gomis-Couto, J. Villacorta-Perez, and C. Quereda-Rodriguez-Navarro Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen Nefrologia 32 6 2012 767 776
6. P.K. Li, K.M. Chow, T.Y. Wong, C.B. Leung, and C.C. Szeto Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study Ann Intern Med 139 2 2003 105 112
7. H. Suzuki, Y. Kanno, S. Sugahara, H. Okada, and H. Nakamoto Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD Am J Kidney Dis 43 6 2004 1056 1064
8. Y. Itoh, T. Fujikawa, and Y. Toya Effect of renin-angiotensin system inhibitor on residual glomerular filtration rate in hemodialysis patients Ther Apher Dial 16 6 2012 554 559
9. L.M. Moist, F.K. Port, and S.M. Orzol Predictors of loss of residual renal function among new dialysis patients J Am Soc Nephrol 11 3 2000 556 564
10. C.D. Peters, K.D. Kjaergaard, B. Jespersen, K.L. Christensen, and J.D. Jensen Renal and cardiovascular effects of irbesartan in dialysis patients - a randomized controlled trial protocol (SAFIR study) [abstract] Dan Med J 60 4 2013 A4602
11. K.D. Kjaergaard, M. Rehling, J.D. Jensen, and B. Jespersen Reliability of endogenous markers for estimation of residual renal function in haemodialysis patients Clin Physiol Funct Imaging 33 3 2013 224 232
12. A.M. Kappelgaard, M.D. Nielsen, and J. Giese Measurement of angiotensin II in human plasma: technical modifications and practical experience Clin Chim Acta 67 3 1976 299 306
13. M.P. Fay, and P.A. Shaw Exact and asymptotic weighted logrank tests for interval censored data: the interval R package J Stat Software 36 2 2010 1 34 http://www.jstatsoft.org/v36/i02/ Accessed April 6, 2014
14. R Core Team R: A Language and Environment for Statistical Computing 2013 R Foundation for Statistical Computing Vienna, Austria
15. I. Kolesnyk, M. Noordzij, F.W. Dekker, E.W. Boeschoeten, and R.T. Krediet Treatment with angiotensin II inhibitors and residual renal function in peritoneal dialysis patients Perit Dial Int 31 1 2011 53 59
16. E. Hur, M. Usta, and H. Toz Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial Am J Kidney Dis 61 6 2013 957 965
17. S.W. Han, Y.W. Won, J.H. Yi, and H.J. Kim No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients Nephrol Dial Transplant 22 4 2007 1150 1155
18. A. Davenport, C. Cox, and R. Thuraisingham Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension Kidney Int 73 6 2008 759 764